Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L R Levine

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|March 1, 1994
Fluoxetine: a randomized clinical trial in the treatment of obesityD J Goldstein, A H Rampey, G G Enas, et al.
Bone|May 20, 2003
Anabolic action of parathyroid hormone on cortical and cancellous bone differs between axial and appendicular skeletal sites in miceH Zhou, A Iida-Klein, S S Lu, et al.
International Journal of Obesity|January 1, 1989
Use of fluoxetine, a selective serotonin-uptake inhibitor, in the treatment of obesity: a dose-response study (with a commentary by Michael Weintraub)L R Levine, G G Enas, W L Thompson, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|March 1, 1994
Fluoxetine: a randomized clinical trial in the treatment of obesityD J Goldstein, A H Rampey, G G Enas, et al.
Bone|May 20, 2003
Anabolic action of parathyroid hormone on cortical and cancellous bone differs between axial and appendicular skeletal sites in miceH Zhou, A Iida-Klein, S S Lu, et al.
International Journal of Obesity|January 1, 1989
Use of fluoxetine, a selective serotonin-uptake inhibitor, in the treatment of obesity: a dose-response study (with a commentary by Michael Weintraub)L R Levine, G G Enas, W L Thompson, et al.
Pageof 2